Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | EPOR | P19235 | 1/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.42 |
| ▸ | ECE1 | P42892 | 1/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7550184 | 1.00 | LTA4H (0.51) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| SCHEMBL676143 | 0.92 | LTA4H (0.57) | LTA4HMMP2DPP8DPP7ANPEP | |
| SCHEMBL730307 | 0.92 | LTA4H (0.57) | LTA4HMMP2DPP8DPP7ANPEP | |
| Hydrochloric Acid SCHEMBL9394094 | 0.90 | LTA4H (0.56) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| SCHEMBL8618743 | 0.90 | LTA4H (0.56) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| Hydrochloric Acid SCHEMBL29401201 | 0.90 | LTA4H (0.56) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| Hydrochloric Acid SCHEMBL9394090 | 0.90 | LTA4H (0.56) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| Hydrochloric Acid SCHEMBL6671170 | 0.89 | LTA4H (0.55) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| Ethylene Glycol SCHEMBL28081329 | 0.88 | LTA4H (0.54) | LTA4HMMP2ITGB3ITGA2BDPP8 | |
| SCHEMBL4622400 | 0.87 | LTA4H (0.52) | LTA4HMMP2DPP8DPP7ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0941123-B1 | NUCLEIC ACID COMPLEXED WITH CATIONIC POLYMER USEFUL FOR GENE THERAPY | HYBRID SYSTEMS LTD (GB) | 2002-06-12 | — | — | EP | disclosed |
| US-6312727-B1 | SYNTHETIC POLYMER CARRIER VEHICLE FOR DELIVERY OF NUCLEIC ACID TO TARGET CELLS IN BIOLOGICAL SYSTEMS | HYBRID SYSTEMS LIMITED (GB) | 2001-11-06 | — | — | US | disclosed |
| EP-0941123-A2 | DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS | SCHACHT, Etienne Honoré (BE) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998019710-A2 | DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS | SCHACHT ETIENNE HONORE (BE) | 1998-05-14 | — | — | WO | disclosed |